Evidence map›Paper›PMID 29020988›Full record

ArticleBMC pharmacology & toxicology2017

Haloperidol affects bones while clozapine alters metabolic parameters - sex specific effects in rats perinatally treated with phencyclidine.

Tatjana Nikolić, Milan Petronijević, Jelena Sopta, Milica Velimirović, Tihomir Stojković, Gordana Jevtić Dožudić, Milan Aksić, Nevena V Radonjić, Nataša Petronijević

Open access · goldAbstract read
In one paragraph

Article in BMC pharmacology & toxicology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Selective 5-HTPharmaceuticals (Basel, Switzerland) · 2023
    Article
  6. Article
  7. Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Tatjana NikolićInstitute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.
Milan PetronijevićMilitary Medical Academy, Clinic of Rheumatology, University of Defence, Belgrade, Serbia.
Jelena SoptaInstitute of Pathology, School of Medicine, University of Belgrade, Belgrade, Serbia.
Milica VelimirovićInstitute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.
Tihomir StojkovićInstitute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.
Gordana Jevtić DožudićInstitute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia.
Milan AksićInstitute of Anatomy "Niko Miljanic", School of Medicine, University of Belgrade, Belgrade, Serbia.
Nevena V RadonjićDepartment of Psychiatry, University of Connecticut School of Medicine, Farmington, CT, USA.
Nataša PetronijevićInstitute of Medical and Clinical Biochemistry, School of Medicine, University of Belgrade, Belgrade, Serbia. natasapetronijevic@yahoo.com.
University of Belgrade · RSMilitary Medical Academy · RSUniversity of Connecticut · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe presentation of schizophrenia (SCH) symptoms differs between the sexes. Long-term treatment with antipsychotics is frequently associated with decreased bone mineral density, increased fracture risk and metabolic side effects. Perinatal phencyclidine (PCP) administration to rodents represents an animal model of SCH. The aim of this study was to assess the effects of chronic haloperidol and clozapine treatment on bone mass, body composition, corticosterone, IL-6 and TNF-α concentrations and metabolic parameters in male and female rats perinatally treated with PCP.

methodsSix groups of male and six groups of female rats (n = 6-12 per group) were subcutaneously treated on 2nd, 6th, 9th and 12th postnatal day (PN), with either PCP (10 mg/kg) or saline. At PN35, one NaCl and PCP group (NaCl-H and PCP-H) started receiving haloperidol (1 mg/kg/day) and one NaCl and PCP group (NaCl-C and PCP-C) started receiving clozapine (20 mg/kg/day) dissolved in drinking water. The remaining NaCl and PCP groups received water. Dual X-ray absorptiometry measurements were performed on PN60 and PN98. Animals were sacrificed on PN100. Femur was analysed by light microscopy. Concentrations of corticosterone, TNF-α and IL-6 were measured in serum samples using enzyme-linked immunosorbent assay (ELISA) commercially available kits. Glucose, cholesterol and triacylglycerol concentrations were measured in serum spectrophotometrically.

resultsOur results showed that perinatal PCP administration causes a significant decrease in bone mass and deterioration in bone quality in male and female rats. Haloperidol had deleterious, while clozapine had protective effect on bones. The effects of haloperidol on bones were more pronounced in male rats. It seems that the observed changes are not the consequence of the alterations of corticosterone, IL-6 and TNF-α concentration since no change of these factors was observed. Clozapine induced increase of body weight and retroperitoneal fat in male rats regardless of perinatal treatment. Furthermore, clozapine treatment caused sex specific increase in pro-inflammatory cytokines.

conclusionTaken together our findings confirm that antipsychotics have complex influence on bone and metabolism. Evaluation of potential markers for individual risk of antipsychotics induced adverse effects could be valuable for improvement of therapy of this life-long lasting disease.

Indexed as

AnimalsAntipsychotic AgentsBone and BonesBone DensityClozapineCorticosteroneFemaleHaloperidolInterleukin-6MalePhencyclidineRats, WistarSchizophreniaSex CharacteristicsTumor Necrosis Factor-alphaAntipsychotic AgentsClozapineCorticosteroneHaloperidolInterleukin-6PhencyclidineTumor Necrosis Factor-alphaBone mineral densityClozapineCorticosteroneHaloperidolInterleukinPhencyclidineSchizophrenia

Identifiers

PMID29020988
PMCPMC5637335
OpenAlexW2761344063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.